asulacrine has been researched along with Colonic Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atwell, GJ; Baguley, BC; Denny, WA; Rewcastle, GW | 1 |
Atwell, GJ; Baguley, BC; Denny, WA; Finlay, GJ; Rewcastle, GW | 1 |
Baguley, BC; Finlay, GJ | 1 |
Clark, GM; Elslager, EE; Lathan, B; Von Hoff, DD | 1 |
Baguley, BC; Corbett, TH; Griswold, DP; Leopold, WR; Plowman, J | 1 |
5 other study(ies) available for asulacrine and Colonic Neoplasms
Article | Year |
---|---|
Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
Topics: Amsacrine; Animals; Antineoplastic Agents; Carcinoma; Cell Line; Chemical Phenomena; Chemistry; Colonic Neoplasms; DNA; Humans; Leukemia, Experimental; Lung Neoplasms; Mice; Oxidation-Reduction; Structure-Activity Relationship | 1987 |
Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
Topics: Acridines; Aminoacridines; Amsacrine; Animals; Cell Line; Chemical Phenomena; Chemistry; Colonic Neoplasms; DNA; Humans; Leukemia L1210; Leukemia P388; Mice; Solubility; Structure-Activity Relationship | 1986 |
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Evaluation of an amsacrine analog in a human tumor cloning system.
Topics: Amsacrine; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Resistance; Humans; Lung Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Experimental antitumor activity of the amsacrine analogue CI-921.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains | 1987 |